Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
23847studies shown
Showing 16,405-16,416 of 23,847
Drug study icon
CompletedNCT01059539

Long-term Safety and Tolerability of Cariprazine for Bipolarity type I

This study exists to understand how this type of care holds up over time after the earliest research stage. For people living with Bipolarity, that matters because care needs to work in daily life, not just in theory.

Multiple locations, including Springdale
BipolarityDrugA study involving a medication or substance.From 18 Years to 65 Years
Countries
United States, Hungary, Poland, ...
Sponsor
Forest Laboratories
Condition
Bipolarity
Drug study icon
Enrolling By InvitationNCT04987229

Long-term Safety Extension Study of OLZ/SAM in Pediatric Subjects

This study is looking at care and outcomes for people with Bipolarity I or Schizophrenia. Taking part may give some people access to OLZ/SAM, but direct benefit is not guaranteed.

Multiple locations, including Dothan
Schizophrenia, BipolarityDrugFrom 10 Years to 17 Years
Countries
United States, Argentina, Brazil, ...
Sponsor
Alkermes, Inc.
Condition
Schizophrenia, Bipolarity
Drug study icon
CompletedNCT02168127

Long-Term Safety of PRC-063 in Adolescents and Adults With ADHD

This study exists to understand how the medication PRC-063 holds up over time after the earliest research stage. Researchers are trying to understand whether the medication PRC-063 can improve attention, thinking, or day-to-day functioning.

Multiple locations, including Los Angeles
ADHDDrugOver 12 Years
Countries
United States, Canada
Sponsor
Rhodes Pharmaceuticals, L.P.
Condition
ADHD
Drug study icon
TerminatedNCT04708834

Long-term Safety Study of Adjunctive Troriluzole in Subjects With OCD

This study exists to better understand the safety of the medication Adjunctive and how manageable it feels in practice. For people living with OCD, that matters because care needs to work in daily life, not just in theory.

Multiple locations, including Chandler
OCDDrugFrom 18 Years to 65 Years
Countries
United States, Canada, United Kingdom, ...
Sponsor
Biohaven Pharmaceuticals, Inc.
Condition
OCD
Drug study icon
CompletedNCT06423781

Safety study of BHV-7000 in depression

This study is completed in the United States. It is testing BHV-7000 for depression.

Multiple locations, including Chandler
DepressionDrugFrom 18 Years to 75 Years
Countries
United States
Sponsor
Biohaven Therapeutics Ltd.
Condition
Depression
Drug study icon
CompletedNCT01244828

Asenapine for schizophrenia

This study is completed. It is testing asenapine for schizophrenia.

Location not clearly listed
SchizophreniaDrugOver 20 Years
Countries
Sponsor
Organon and Co
Condition
Schizophrenia
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.